A previous study Showed that microporous, compliant and (bio)degradable vascular prostheses prepared from a polyurethane/poly(t.-lactic acid) mixture can function as a temporary scaffold for the regeneration of small-calibre arteries. In this study the mechanism of fragmentation of vascular prostheses made of polyurethane, copolyesterether and blends of either polyurethane or copolyesterether with polymers differing in biodegradability, crystallinity and glass transition temperature is investigated. Animal studies revealed that after 6 wk of implantation only the prostheses made of blends containing a second polymer which was nonelastic at 37°C were fragmented extensively, whether the second polymer was (bio)degradable or not. It is concluded that fragmentation of the prostheses is mainly caused by alternating stresses induced by the arterial pulsations and that (bio}degradation plays a minor role.
In viva fragmentation of microporous polyurethane-and copolyesterether elastomer-based vascular prostheses A previous study Showed that microporous, compliant and (bio)degradable vascular prostheses prepared from a polyurethane/poly(t.-lactic acid) mixture can function as a temporary scaffold for the regeneration of small-calibre arteries. In this study the mechanism of fragmentation of vascular prostheses made of polyurethane, copolyesterether and blends of either polyurethane or copolyesterether with polymers differing in biodegradability, crystallinity and glass transition temperature is investigated. Animal studies revealed that after 6 wk of implantation only the prostheses made of blends containing a second polymer which was nonelastic at 37°C were fragmented extensively, whether the second polymer was (bio)degradable or not. It is concluded that fragmentation of the prostheses is mainly caused by alternating stresses induced by the arterial pulsations and that (bio}degradation plays a minor role.
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No suitable material for the reconstruction of arteries of small diameter is available.
A high incidence of graft failure can often be ascribed to a lack of compliance and/ or the poor healing characteristics of the materials used'-5. However, recent studies have shown that grafts which are elastic, microporous and biodegradable are promising 6-12. Prostheses with these characteristics were prepared from a polyurethane/poly(L-lactic acid) mixture13* 14, When replacing a 1 cm segment of the abdominal aorta of a rat by such a prosthesis the graft acts as a temporary scaffold for the regeneration of the arterial wall. Simultaneously with the regeneration of the arterial wall, the prosthesis fragments.
In the ideal case the rate of tissue regeneration and the rate of disintegration of the prosthesis correspond such that the mechanical properties of the graft together with the ingrown tissue remain the same in time. Remarkable in the study mentioned was the very high rate of regeneration of the arterial wall. Within 6 wk almost complete healing of the graft was observed. Even more remarkable was the very high rate of fragmentation of the prosthetic material which appeared to be dependent on the polyurethane/ poly(L-lactic acid) ratio and the molecular weight of poly(L-lactic acid). Implantation of prostheses of polyurethane/poly(L-lactic acid) (80120 w/w) using a polyjtlactic acid) with viscosity-average mol wt 100 000 resulted in aneurysms after 6 wk indicating extensive -Correspondence to Professor J. Feijen. fragmentation of the prosthetic material. In contrast no aneurysms were observed when using prostheses prepared from polyurethane/poly(L-lactic acid] (954 w/w) using poly(L-lactic acid) with viscosity-average moi wt 500 000 indicating reduced fragmentation.
However, pinoc~tosis of fragments of the prosthetic material by multinucleated giant cells after 6 wk of implantation was observed indicating fragmentation of the graft. Finally, grafts prepared from pure polyurethane showed no fragmentntion after 6 wk of implantation.
Two mechanisms have been proposed to explain the unexpected behaviour of the blend materials. In the first mechanism, (bio)degradation of poly(L-lactic acid) is supposed to cause fragmentation of the prosthesis14. However, the degradation rate of poly(L-lactic acid] is rather 10~'~' 16. Because the degradation of this (semi)crystalline polymer predominantly proceeds via the amorphous phase"-" a high rate of degradation can only be expected when poly(L-lactic acid) in the blend has a decreased crystallinity which may be caused by an even distribution of the poly(I.-lactic acid) chains over the polyurethane matrix. In the second mechanism, exposure of the graft to alternating mechanical stresses caused by the arterial pulsations is supposed to cause fragmei~tation of the prosthesis'*. In this case it is assumed that poly(r,-lactic acid) forms rigid domains in an elastic matrix of polyurethane.
Stress concentrations around these rigid domains, caused by the stresses exerted on the prostheses, will result in small ruptures which will propagate of vascular prostheses:
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through the polyurethane matrix leading to fragmentation of the graft.
blends of Hytrel and PLLA (LM), PLLA (HM), PSF or PEU (9/l w/w). In this study we investigated whether the high rate of fragmentation is restricted to the combination polyurethane/poly(L-lactic acid) and which mechanism underlies this behaviour.
Microporous and elastic vascular prostheses were made of polyurethane, copolyesterether and blends of either polyurethane or copolyesterether with polymers differing in biodegradability, crystallinity and glass transition temperature. The prostheses were used to replace a 1 cm segment of the abdominal aorta in rats. At 6 wk after implantation the degree of fragmentation of the grafts was studied. The various blends were investigated by differential scanning calorimetry, scanning electron microscopy and dynamic mechanical measurements.
The degree of fragmentation could be related with the physical/chemical properties of the polymers and the distribution of the polymers in the blends.
On the basis of the results a model is proposed for a clinically applicable (bioldegradable vascular prosthesis.
The PEU-based prostheses were prepared by a modified dipcoating procedure developed by Gogolewski et all33 14. A glass rod with the desired diameter was dipped into a suspension of a polymer solution and sodium citrate particles (for compositions see Table 2 ). The temperature of the casting suspensions was adjusted such that the casting procedure resulted in the deposition of thin and regular layers on to the glass rod. For the various compositions, the temperature had to be adjusted to different levels between 40 and 6O'C. Subsequently, the glass rod on which a layer of the suspension was deposited was transferred into ethanol/water at 12/O, 111 1 or 10/2 (v/v) for 10 s at room temperature.
Thereafter, the glass rod was transferred into ethanol/water at 7/5 (v/ v) also at room temperature.
After 5-10 min the precipitated polymer was dried by air exposure and the subsequent layer was deposited by the same procedure. After the desired number of layers was prepared the prostheses were placed in ethanol/water at 7/5 (v/v) for at least 30 min. Subsequently, they were placed in a water bath at 40-50°C for 2 h to dissolve the salt particles. The prostheses were then thoroughly rinsed with distilled water and ethanol, removed from the glass rods and stored in ethanol.
MATERIALS AND METHODS

Materials
Polymers were used after being purified by precipitation from solutions into non-solvents (see Table 1 
Graft preparation
Microporous elastic vascular prostheses with the following compositions [see Table I for abbreviations) were prepared: PEU and blends of PEU and PEW, PCL, PGLY, PLLA [MM), PLLA (HM), or PSF (9/l w/w), and Hytrel and
The Hytrel-based prostheses were prepared in a similar way. Also these prostheses were prepared by depositing a number of porous layers on to a glass rod by dipcoating. However, the method of polymer precipitation was changed:
after the glass rod was dipped into a polymer solution/salt particles suspension (for composition see Table Z ], the glass rod containing the layers was exposed to air allowing the solvent to evaporate. After 1-3 min the next layer was formed by the same procedure. Dipcoating was performed at room temperature, and repeated until the required wall thickness was obtained. Subsequently the prostheses were exposed to air for at least 30 min. Thereafter, they were treated like the PEU-based prostheses.
Characterization of the grafts
The prostheses were evaluated for porosity, ruptures, pinholes, regularity of the wall thickness and linkage of ._ 'PGLY does not dissolve in DMF/THF mixtures. PGLY with a particle size < 5,um was suspended in the PEU solutions.
f Since DMF/THF mixtures are poor solvents and CHCI, is a good solvent for PLLA, before the casting procedure, a solution of PLLA in CHCI, was added dropwise under vigorous stirring to a solution of PEU in a mixture of DMF and THF until a solution with the desired composition was obtained.
For abbreviations of polymers se& fable 7
the subsequent layers with a Zeiss stereo light microscope. The wall thickness was determined by light microscopy. After being coated with a layer of gold by a Balzer sputter unit, the pore structure of the prostheses was examined with a Jeol JSM 35 scanning electron microscope (SEM) operating at 15 kV.
The longitudinal elasticity of the prostheses was determined as follows. Shortly before the measurements, the prostheses were rinsed with distilled water and subsequently fixed between the clamps of a Instron tensile tester (Floor model TT-CM). The prostheses of length 1 cm were drawn at 0.5 cmlmin to 2 cm. The measured stress at this strain gave the F,,,, value.
In a number of cases stress-strain measurements in the radial direction were also performed. Prostheses of length 0.5 cm were drawn at 0.5 cmimin with the setup shown in Figure 2 . The measured stress and elongation at failure gave the SF and the EF values respectively.
Compatibility of the blends
A number of techniques were applied to evaluate the compatibility of the blends. Both dense membranes and porous prostheses were investigated. The dense membranes were prepared by solution casting techniques.
The crystallinity of PCL and PLLA in the prostheses made of PEU/PCL, PEU/PLLA (MM), PEU/PLLA (HM), Hytrel/PLLA (LM) and Hytrel/PLLA (HM) (Q/l w/w) and in the dense membranes made of Hytrel/PLLA (LM) and HytrellPLLA (HM) (911 w/w) and of starting materials PCL and PLLA were determined by differential scanning calorimetry (Du Pont 990 thermal analyser) using a heating rate of lO"C/min.
Glass transition temperatures of prostheses and dense membranes made of Hytrel and blends of Hytrel and PLLA (LM), PLLA (HM), PSF and PEU (Q/l w/w) were determined with a Myrenne ATM 3 torsion pendulum instrument operating at 1 Hz and a heating rate of 1"Clmin. The maximum of the G" curve was taken as Ts.
The presence of the second polymer in a number of blends was visualized as follows. Dense membranes made of Hytrel and blends of Hytrel and PLLA (LM), PLLA (HM), PSF and PEU (9/l w/w) were cut at -140°C with an LKB 2188 Nova cryo-ultratome to obtain crosssections of the materials. The specimens were placed in l,+dioxane at room temperature for 15-80 min to remove the second polymers in the blends. After drying, the 1,4-dioxane-treated and untreated samples were sputter-coated with gold and examined with SEM.
Implantation
Prostheses of length 1 cm were used to replace a 1 cm segment of the abdominal aorta of adult male Wistar rats (n = 3). The implantation was performed according to a standardized procedure". The grafts were harvested 6 wk after implantation and stored in ethanol.
Trypsinhollagenase treatment
The explanted grafts were thoroughly rinsed with distilled water and subsequently incubated with 10% t~sin/E~TA (Gibco Europe, Breda, The Netherlands) at 37°C for 24 h. Then the trypsin/EDTA solution was replaced by a 0.8% solution of collagenase (type 1, Sigma, St Louis, USA) in phosphate-buffered saline (NPBI, Emmer-Compascuum, The Netherlands). After 2-4 d, the grafts were thoroughly rinsed with distilled water, examined macroscopically, and in some cases subjected to mechanical tests. Unimplanted prostheses served as controls. Figure 2 shows SEM photographs of the PEU and the Hytrel prostheses. The morphology of the grafts can be described as a highly interconnected sponge-like structure. The pore diameter on the inner side of the prostheses was 80 nm and on the outer side 75 pm. The prostheses made of the blends had a similar appearance.
RESULTS
Graft preparation
Wall density varied with the composition of the graft material from 0.11 to 0.30 mg/mm3 giving a volume porosity of about QO-70% (TabJe3). The F,,,, and the wall thickness varied with the composition of the graft material and were 0.40-1.95 N and 0.30-0.60 mm respectively (Table 3) .
It was attempted to prepare the various types of prostheses with the same characteristics such as wall thickness, elasticity and porosity. However, due to variation of the mechanical properties of the polymers, phase separation, and/or the viscosity of the casting Biomaterials 1992, Vol. 13 NO. 9
Figure 2 Scanning electron micrographs of a the PEU and b the Hytrel prostheses. suspensions this was not always possible (Table 3) . To prepare the PEU/PLLA(MM) and the PEU/PLLA(HM) prostheses with sufficient strength, it was necessary to reduce the sodium citrate concentration in the casting suspensions thereby reducing the porosity of the resultant prostheses as compared with the other PEU-based prostheses. Hytrel has a higher E modulus than PEUz3. The Hytrel-based prostheses exhibited higher Floes than the PEU-based prostheses,
Compatibility
From differential scanning calorimetry, it appeared that the c~stallinity of PCL in the prosthesis was reduced to 75% as compared to the starting material (' Table 4 )'l, ". Thus a large fraction of PCL had formed crystalline domains. A reduction of the crystallinity of PCL in the blend compared to the starting material might indicate some mixing of the PCL chains over the PEU matrix, but it is also possible that domains with reduced c~stallinity were formed. The differential scanning calorimetry thermograms of the PEU/PLLA(MM) and the PEU/ PLLA(HM) prostheses showed two peaks between 160 and 18O'C. The melting enthalpies of the two peaks together and of the starting materials were nearly equal, indicating a strong inhomogeneous distribution of the polymers in the blend. Leenslag et al., who also studied the melting behaviour of PEU/PLLA blends, found two peaks in the thermogramsl'.
It was suggested that two types of crystal lattices were formed, one type was supposed to consist of pure PLLA while in the other PEU For abbreviations of polymers see Table 7 .
chains are entrapped in the PLLA matrix. However, others have found that under certain conditions pure PLLA can also yield two melting peaks in the thermograms (H. Esselbrugge and J. Feijen, personal communication).
This may be caused by the formation of two types of crystal lattices differing in size or structure or both. In the Hytrel/PLLA(LM) and the Hytrel/PLLA(HM) prostheses, PLLA was also partially crystalline indicating an inhomogeneous distribution of the polymers in the blend. In contrast to the PEU/PLLA prostheses, the thermograms of both types of prostheses showed single melting peaks at 172°C. A crystallinity of PLLA(LM) and PLLA(HM) in the blends of respectively 60% and 50% compared to the starting materials was found. As with the PEU/PCL prostheses, the reduction of the crystallinity of PLLA in the blends compared to the starting materials might be caused by some mixing of PLLA chains over the Hytrel matrix or by the formation of domains with a reduced crystallinity.
The Furthermore, the Tg of PLLA(LM) and PLLA(HM) could not be detected in the G" curve. Presumably this is because PLLA in both the glassy and the rubbery phase possesses a much higher E modulus than Hytrel. As a consequence the energy is transferred to the Hytrel matrix and not to the hard PLLA domains independently whether PLLA is in the glassy or the rubbery phase. The glass transition of PSF could not be detected in the G" curve because the Tg of PSF (18O'C) is higher than the T,,, of Hytrel. Also in the G" curve of the Hytrel/PEU prosthesis, only one maximum at -60°C was observed. Since there is only a small difference in the Tg of Hytrel and PEU (T,(PEU) -40°C) it remains unclear whether the maximum is the result of one or two glass transitions.
The differences between the Tg of the pure components in the blend made of Hytrel and PLLA(LM), PLLA(HM) or PSF are large enough to expect a shift in the Tg when homogeneous blends were formed. Therefore, the observed absence of a shift indicates that the polymers were inhomogeneously distributed over the blends. In contrast, the difference between the T, of Hytrel and PEU is too small and no conclusion can be drawn about the distribution of these polymers in this blend. Furthermore, the dynamic torsion measurements on the porous prostheses and the dense membranes yielded the same results indicating that the distribution of the polymers in both types of blends were comparable.
PLLA(LM), PLLA(HM), PSF and PEU are soluble in 1,4-dioxane, whereas Hytrel is not. Therefore, if these polymers should form domains in the blends they should In these experiments, dense membranes were used instead of porous structures because with the use of porous structures the pores initially present and the pores which possibly arise as a result of the extraction procedure cannot be distinguished. The untreated Hytrel samples and those treated with 1,4-dioxane had non-porous surfaces. The other samples showed porous surfaces indicating that pores had been formed by dissolution of PLLA(LM), PLLA(HM), PSF and PEU from the blends and that indeed these polymers had formed domains.
The pore size differed with composition and varied between 1 and 10 ,um (Figures 3a  and b show a scanning electron micrograph of untreated and l,Cdioxane-treated Hytrel/PLLA(HM) membrane respectively).
Because the dense membranes and the porous prostheses were prepared in a comparable way it can be assumed that in the prostheses PLLA(LM], PLLA(HM), PSF and PEU have also formed domains in the Hytrel matrices. However, the sizes of the domains in the dense membranes and in the prostheses do not have to be necessarily the same.
Implantation and trypsinhollagenase treatment
The 12 different types of prostheses (length 1 cm) were implanted in the abdominal aorta of rats (n = 3) and evaluated after 6 wk of implantation.
At graft harvesting, all the implants were patent. The PEU/PLLA(MM) and one of the Hytrel/PLLA(LM) prostheses showed aneurysms, whereas the other prostheses were not dilated. Furthermore, all the prostheses showed an extensive perigraft tissue ingrowth. This ingrown tissue was removed by trypsin/collagenase treatment to leave bare prosthetic material.
After this, a degree of fragmentation was assessed by visual examination or by tensile measurements (Table 5 ). The PEU/PLLA(MM), PEU/PCL, and PEU/PSF prostheses showed large ruptures and had lost their mechanical strength completely (Figure 4a is a light micrograph of an explanted and trypsin/collagenasetreated PEU/PSF prosthesis]. The PEU/PLLA(HM) and PEU/PGLY prostheses showed no visual signs of fragmentation However, these prostheses lost their mechanical strength completely. A slight decrease of mechanical strength of the PEU and the PEU/PESU prostheses could be determined by stress-strain measurements. Table 1 .
prostheses is related to the physical/chemical properties of the polymers (Tables 5 and 6 ). Only prostheses made of blends of either PEU or Hytrel and polymers which are non-elastic at 37°C showed fragmentation whereas prostheses prepared from pure PEU or Hytrel or blends of either PEU or Hytrel and polymers which are elastic at 37°C remained relatively unaffected after 6 wk of implantation, Extraction experiments showed that the second polymers had formed domains in the Hytrel blends.
Also differential scanning calorimetry and dynamic torsion measurements showed that the polymers were inhomogeneously distributed in the blends. Differential scanning calorimetry measurements on the PELJi PLLA prostheses showed that PEU and PLLA were also inhomogeneously distributed. The crystallinity of PLLA in these blends was even higher than in the Hytrel/PLLA blends. Therefore we expect that PLLA in the PEU/ PLLA blends will not degrade more rapidly than pure PLLA and that PLLA also formed domains in the PEU matrices.
Most likely the other second polymers had formed domains in the PEU blends. We conclude that fragmentation of the prostheses made of either PEU or Hytrel and polymers which are non-elastic at 37°C is mainly caused by alternating stresses induced by the pulsations and that (bio)degradation plays a minor role.
The rigid polymers which form domains in the PEU and the Hytrel matrices can be regarded as rigid filler particles for the elastomer. In a large variety of rubber products rigid particles, usually carbon blacks, are frequently applied. One of the objectives is to improve the mechanical properties of the rubber. Important parameters are the adhesion of the filler particles and the rubber and the size of the filler particles. In the case of carbon blacks, reinforcement is obtained because of the specific interaction and the large contact area between the rubber matrix and the filler particles.
With our prostheses a strong adherence between the PEU or Hytrel matrices and the domains formed by the second polymers is not likely and since the domain size is several micrometres in diameter the contact area is relatively small. Therefore these filler particles will have a counteracting effect on the mechanical properties of the prostheses and should be regarded as flaws. Since flaws act as stress concentrators during repeated stretching, the failure process is initiated near these domains. This process may be influenced by surrounding fluids (stress corrosion] whereby the rate of degradation of the (bio)degradable polymer is not influenced. Differences in the degree of fragmentation were found for the different prostheses made of blends of either PEU or Hytrel and polymers which are non-elastic at 37°C. For example the PEU/PLLA (MM) and the Hytrel/PLLA(LM) prostheses were fragmented more extensively than the PEU/PLLA (HM) and the Hytrel/PLLA(HM) prostheses respectively. Since low-molecular-weight PLLA degrades faster than high-molecular-weight PLLA there may be some influence of (bio)degradation on the fragmentation rate. But it is also possible that the size of the PLLA domains in the different prostheses was not equal which will also affect the fragmentation rate. The in viva behaviour of the Hytrel-based prostheses corresponds to that of the PEU-based prostheses but the differences in the degree of fragmentation of the Hytrel-based prostheses are less pronounced than those of the corresponding PEU-based prostheses. Several reasons may account for this. The adherence of the non-elastic domains to the elastic matrix and the size of the domains are most likely not the same in both types of prostheses. These differences will strongly affect the fragmentation rate. Furthermore differential scanning calorimetry showed differences in the crystallinity of PLLA in the PEU/PLLA and the Hytrel/PLLA blends. These differences might be related to differences in the degree of compatibility of the polymers which in turn will influence the fragmentation rate.
Despite the excellent results obtained with the PEU/ PLLA prostheses in viva, care must be exercised to apply these types of prostheses clinically. As has been shown by van der Lei et al., polymer particles of the fragmented prostheses are engulfed by multinucleated giant cells7*s. However, it is unknown how long it takes until the polymer particles are degraded completely and whether the degradation products accumulate in the body. Furthermore, evidence has been gathered that toxic compounds are generated during the degradation of polyurethanes.
Especially when the hard segments of the used polyurethanes are composed of aromatic diisocyanates like methylene bis (p-phenylisocyanate) in for example Biomer@, Mitrathane@, Pellethane@ 2363 series and Estane@ gi'14f1, aromatic diamines are formed which are carcinogenic, mutagenic and very toxic24-30. Promising in this regard is the work of Bruin et al. 31 who synthesized polyester-urethane elastomer networks from the nontoxic compounds L-lactic acid, glycolide, e-caprolactone, lysine and mycoinositol.
In principle, the choice of the polymers is not restricted to polyurethanes.
Also, the application of other polymers with elastomeric properties at 37°C can be considered. Such elastomers should meet the following requirements.
The elastomer must degrade into non-toxic compounds, preferably into naturally occurring metabolites. The physical and chemical properties of the elastomer must be such that a prosthesis with the desired pore structure and mechanical properties can be prepared.
The surface characteristics of the elastomer must be such that the prosthesis allows ingrowth and overgrowth of the surrounding tissue thereby inducing regeneration of the arterial wall. The elastomer and its degradation products must not provoke undesired tissue reactions. the degradation rate of the prosthetic material must be balanced with the regeneration rate of the arterial wall. This study has shown that when an elastomer is blended with a non-elastic incompatible polymer the non-elastic polymer forms domains in an elastic matrix. As a consequence, the fragmentation rate is enhanced. The fragmentation rate can be adjusted by changing the type of non-elastic polymer or changing the elastomer/nonelastic polymer ratio or both.
